期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
温敏性PCL-PEG-PCL水凝胶的合成、表征及蛋白药物释放 被引量:11
1
作者 苗博龙 马桂蕾 宋存先 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2009年第12期2508-2513,共6页
考察了温敏性PCL-PEG-PCL水凝胶中聚乙二醇(PEG)及聚己内酯(PCL)不同嵌段组成对其溶胶-凝胶相转变温度以及亲水性药物(牛血清白蛋白,BSA)释放速率的影响.采用开环聚合法,以辛酸亚锡为催化剂、PEG1500/PEG1000为引发剂,与己内酯单体发生... 考察了温敏性PCL-PEG-PCL水凝胶中聚乙二醇(PEG)及聚己内酯(PCL)不同嵌段组成对其溶胶-凝胶相转变温度以及亲水性药物(牛血清白蛋白,BSA)释放速率的影响.采用开环聚合法,以辛酸亚锡为催化剂、PEG1500/PEG1000为引发剂,与己内酯单体发生开环共聚,合成了一系列具有不同PEG和PCL嵌段长度的PCL-PEG-PCL型三嵌段共聚物.通过核磁共振氢谱及凝胶渗透色谱对其组成、结构及分子量进行了表征.共聚物的溶胶-凝胶相变温度由翻转试管法测定.利用透射电镜、核磁共振氢谱及荧光探针技术证实了该材料在水溶液中胶束的形成.以BSA为模型蛋白药物,制备载药水凝胶,利用microBCA法测定药物在释放介质中的浓度,研究其体外释放行为.实验结果表明,共聚物的溶胶-凝胶相变温度与PCL及PEG嵌段长度紧密相关,即在给定共聚物浓度情况下,固定PEG嵌段长度而增加PCL嵌段长度,会导致相变温度降低;而固定PCL嵌段长度而增加PEG嵌段长度,其相变温度相应升高.水凝胶中蛋白药物的释放速率与疏水的PCL嵌段长度无关,而与亲水的PEG嵌段长度密切相关,即PEG嵌段越长,蛋白药物释放越快. 展开更多
关键词 PCL-PEG-PCL共聚物 温度敏感 水凝胶 凝胶相变温度 蛋白药物释放
下载PDF
纳米凝胶作为蛋白质药物载体的研究进展 被引量:4
2
作者 张林 李兆明 +2 位作者 陈超 颜东 董世波 《食品与药品》 CAS 2017年第1期57-61,共5页
本文主要综述了纳米凝胶的特性、制备方法、不同的种类作为蛋白质药物载体方面的应用。
关键词 纳米凝胶 蛋白药物载体 溶胀 蛋白药物释放
下载PDF
Release Model of Water-soluble Chitosan Nanoparticles for Protein Delivery 被引量:2
3
作者 王春 孙胜玲 +2 位作者 肖惠宁 何北海 杨连生 《Agricultural Science & Technology》 CAS 2009年第3期144-147,共4页
[Objective] The experiment aimed to explore release rule of water-soluble chitosan (WSC) in vitro. [Method]The bovine serum albumin(BSA) was taken as a model protein drug and some existing release models such as Kinet... [Objective] The experiment aimed to explore release rule of water-soluble chitosan (WSC) in vitro. [Method]The bovine serum albumin(BSA) was taken as a model protein drug and some existing release models such as Kinetics model, Gompertz model, Weibull model, Higuchi model and Logistic model were used to fit the BSA release profile from WSC carriers. [Result] Except Higuchi model and Logistic model, other models could fit BSA release profile better. [Conclusion] Gompertz two-order kinetics model could fit the release of WSC nano-particles better and model parameters had practical physical meaning. 展开更多
关键词 Water-soluble chitosan Nano-particle carriers Protein delivery Release model
下载PDF
Bovine Serum Albumin (BSA) Microspheres Containing Methotrexate (MTX) I.Pharmaceutical Aspects
4
作者 石庭森 陈小平 《Journal of Chinese Pharmaceutical Sciences》 CAS 1993年第1期33-38,共6页
Microspheres Ⅰ,Ⅱ and Ⅲ were produced by emulsion technique.Microsphere I was solidified by glutaraldehyde crosslinking,microsphere Ⅱ was solidified by glutaraldehyde crosslinking and further treated with glycine s... Microspheres Ⅰ,Ⅱ and Ⅲ were produced by emulsion technique.Microsphere I was solidified by glutaraldehyde crosslinking,microsphere Ⅱ was solidified by glutaraldehyde crosslinking and further treated with glycine solution and microsphere Illwas solidified by heating denaturation only.The results showed that the microsphere diameter produced by cross[inking was bigger than that prepared by heating.The microsphere Ⅱ had higher hydrophilicity than Microsphere I had.The methotrexate (MTX) contents in microspheres Ⅰ and Ⅱ were 2.73±0.053%,2.87±0.119% respectively. microsphere Ⅲ was only blank microspheres with MTX adsorbed on their surfaces.In vitro release studies,microspheres I and I have maintained sustained release of MTX till the next day,it was found that the drug releases from microspheres Ⅰ and Ⅱ were governed by Higuchi diffusion law. 展开更多
关键词 Hydrophillic albumin microspheres Emulsion technique METHOTREXATE Drug release kinetics
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部